These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 27885879)

  • 1. A high preoperative carbohydrate antigen 19-9 level is a risk factor for recurrence in stage II colorectal cancer.
    Nozawa H; Ishihara S; Kawai K; Hata K; Kiyomatsu T; Tanaka T; Nishikawa T; Otani K; Yasuda K; Sasaki K; Murono K; Watanabe T
    Acta Oncol; 2017 May; 56(5):634-638. PubMed ID: 27885879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of CDX2 expression and T stage improves prognostic prediction of colorectal cancer.
    Xu W; Zhu Y; Shen W; Ding W; Wu T; Guo Y; Chen X; Zhou M; Chen Y; Cui L; Du P
    J Int Med Res; 2019 May; 47(5):1829-1842. PubMed ID: 30616445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III.
    Nozawa H; Kawai K; Hata K; Tanaka T; Nishikawa T; Otani K; Sasaki K; Kaneko M; Emoto S; Murono K
    In Vivo; 2018; 32(5):1235-1240. PubMed ID: 30150450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG study.
    Chan JK; Tian C; Kesterson JP; Lin KY; Darcy K; Richardson MT; Kapp DS; Monk BJ; McNally L; Landrum L; Copeland L; Walker JL; Wenham RM; Phippen N; Spirtos NM; Tewari K; Shahin M; Berry L; Bell JG
    Gynecol Oncol; 2024 Feb; 181():54-59. PubMed ID: 38134754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic significance of keloid-like collagen remodeling patterns in the extracellular matrix of colorectal cancer.
    Imanbayev NM; Iztleuov YM; Kamyshanskiy YK; Zhumasheva AV
    Pathol Oncol Res; 2024; 30():1611789. PubMed ID: 38903488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.
    Wu C; Pai RK; Kosiorek H; Banerjee I; Pfeiffer A; Hagen CE; Hartley CP; Graham RP; Sonbol MB; Bekaii-Saab T; Xie H; Sinicrope FA; Patel B; Westerling-Bui T; Shivji S; Conner J; Swallow C; Savage P; Cyr DP; Kirsch R; Pai RK
    Clin Cancer Res; 2024 May; 30(9):1811-1821. PubMed ID: 38421684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting 5-year recurrence risk in colorectal cancer: development and validation of a histology-based deep learning approach.
    Xiao H; Weng Z; Sun K; Shen J; Lin J; Chen S; Li B; Shi Y; Kuang M; Song X; Weng W; Peng S
    Br J Cancer; 2024 Apr; 130(6):951-960. PubMed ID: 38245662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy improves prognosis of resectable stage IV colorectal cancer: a comparative study using inverse probability of treatment weighting.
    Nozawa H; Takiyama H; Hasegawa K; Kawai K; Hata K; Tanaka T; Nishikawa T; Sasaki K; Kaneko M; Murono K; Emoto S; Sonoda H; Nakajima J
    Ther Adv Med Oncol; 2019; 11():1758835919838960. PubMed ID: 31019569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel digital signatures of tissue phenotypes for predicting distant metastasis in colorectal cancer.
    Sirinukunwattana K; Snead D; Epstein D; Aftab Z; Mujeeb I; Tsang YW; Cree I; Rajpoot N
    Sci Rep; 2018 Sep; 8(1):13692. PubMed ID: 30209315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of risk factors for postoperative recurrence of stage I colorectal cancer: a retrospective analysis of a large population.
    Wang J; Song Z
    Front Surg; 2024; 11():1388250. PubMed ID: 38712335
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Pu H; Zhang S; Yan S; Li C; Fu J; You D; Zhang T; Li Z
    J Gastrointest Oncol; 2024 Feb; 15(1):179-189. PubMed ID: 38482244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic influence of tumour budding in Western patients with stage II colorectal cancer.
    Canguçu AL; Valério E; Peixoto RBP; Felismino TC; de Mello CAL; Neotti T; Calsavara VF; de Macedo MP; Júnior SA; Riechelmann R
    Ecancermedicalscience; 2020; 14():1130. PubMed ID: 33209121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    Khan H; Radomski SN; Siddiqi A; Zhou N; Paneitz DC; Johnston FM; Greer JB
    J Surg Oncol; 2023 May; 127(6):975-982. PubMed ID: 36790093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer.
    Liu Y; He J; Xu J; Li J; Jiao Y; Bei D; Hu Y; Chen H; Xiao Q; Ding K
    Oncol Lett; 2017 Apr; 13(4):2230-2236. PubMed ID: 28454385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of survival and recurrence in patients with stage I colorectal cancer.
    Bananzadeh A; Bahadori M; Mohammadianpanah M; Pakravan F; Shojaei-Zarghani S; Safarpour AR
    Front Surg; 2024; 11():1377733. PubMed ID: 38817946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum CA19-9 should be routinely measured in the colorectal patients with preoperative normal serum CEA: a multicenter retrospective cohort study.
    Li Z; Zhu H; Pang X; Mao Y; Yi X; Li C; Lei M; Cheng X; Liang L; Wu J; Ding Y; Yang J; Sun Y; Zhang T; You D; Liu Z
    BMC Cancer; 2022 Sep; 22(1):962. PubMed ID: 36076189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal cutoff value of preoperative CEA and CA19-9 for prognostic significance in patients with stage II/III colon cancer.
    Mizuno H; Miyake H; Nagai H; Yoshioka Y; Shibata K; Asai S; Takamizawa J; Yuasa N
    Langenbecks Arch Surg; 2021 Sep; 406(6):1987-1997. PubMed ID: 34148158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Genomic Alterations of Perineural Invasion in Patients with Stage II Colorectal Cancer.
    Su H; Chang C; Hao J; Xu X; Bao M; Luo S; Zhao C; Liu Q; Wang X; Zhou Z; Zhou H
    Onco Targets Ther; 2020; 13():11571-11582. PubMed ID: 33204110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High hnRNP AB expression is associated with poor prognosis in patients with colorectal cancer.
    Zhou JM; Jiang H; Yuan T; Zhou GX; Li XB; Wen KM
    Oncol Lett; 2019 Dec; 18(6):6459-6468. PubMed ID: 31819776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.